Enhancements in precision medication and individualized cancer treatment method boosts demand for cancer biomarkers. The flexibility of biomarkers to detect cancer at its earliest phases, manual therapeutic possibilities, and watch the usefulness of treatment is boosting its adoption through the healthcare industry.Epigenetics section will increase